Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-09-12
Original market date: See footnote 1
2023-09-12
Product name:
ZIMED PF
Description:
PRESERVATIVE-FREE, MULTI-DOSE BOTTLE
DIN:
02533464
Product Monograph/Veterinary Labelling:
Date:
2022-12-13
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
AEQUUS PHARMACEUTICALS INC.
200 Granville Street, Suite 2820
Vancouver
British Columbia
Canada
V6C 1S4
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:40.28
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01EE03 BIMATOPROST
Active ingredient group (AIG) number:See footnote5
0147303001
| Active ingredient(s) | Strength |
|---|---|
| BIMATOPROST | 0.03 % / W/V |